Back to Journals » Drug Design, Development and Therapy » Volume 16
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,000 | Dovepress* | 5,846+ | 376 | 6,222 | |
PubMed Central* | 154 | 92 | 246 | ||
Totals | 6,000 | 468 | 6,468 | ||
*Since 16 May 2022 |
View citations on PubMed and Google Scholar